Trimetazidine Hydrochloride (Retazidine) 35mg Modified Release Tablets are used to treat angina (chest pain) and improve heart function by enhancing the efficiency of the heart muscle. The modified-release formulation ensures a controlled release of the medication, offering prolonged therapeutic effects. Each tablet contains 35mg of trimetazidine hydrochloride, and the pack contains 30 tablets, providing a one-month supply for effective management of angina and heart health. It should be taken as prescribed by a healthcare professional.